Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And yet those of us who are rightly critical of Missling get labeled as FUDsters, paid bashers or whatever.
For some, the truth is just too hard to face and admitting the possibility of being wrong is too threatening to their fragile egos.
There is no evidence at all that anyone here is trying to derail Anavex nor is there any evidence of stock price manipulation in AVXL. There are plenty of people here who want Anavex to have a chance at success and are frustrated that our CEO is a buffoon who can’t get anything done right or on time. But of course conspiracy theories don’t require actual evidence, only conjecture.
Hey George - How many shares are you looking to unload on Thursday? Your MO is clear as a bell. Pump up the stock to get suckers to buy so that you can sell into a rising market on Thursday. Either that or you’re just an altruistic guy who wants to help his message board friends make some money (yeah right🤦♂️).
You’re fooling no one, or at least I hope not.
There’s no evidence whatsoever that Missling has ever learned from his mistakes or that he ever will.
“What the hell did Dr. missing do to piss off the wrong entity?”
He’s an incompetent boob who has enriched himself at shareholders’ expense, that’s what the hell he did.
Keep dreaming.
He sure has.
You claim not to be a pumper but you tell people to BUY, BUY, BUY AVXL and make wild predictions for GREAT, ABSOLUTELY GREAT, and HUGE news day in and day out, week in and week out, month in and month out, year in and year out. If the whole thing wasn't so pathetic it would be funny. You are fooling no one.
Here's the truth: Missling is and has been an unmitigated disaster for shareholders as well as for patients desperately in need of new therapies. He is among the worst CEOs in the history of biopharma. For a hundred good reasons he gets no respect from serious biotech investors. He needs to be replaced.
Expect AVXL to close at or near the low of the day on light selling volume. Clearly there is no anticipation of significant near-term news.
Keep trying. Maybe there are still a few suckers out there who don’t know any better.
I’ll repeat what I said earlier. This is just another lame excuse to let Missling off the hook. First of all, the 87,000 employees at Sanofi are not all working on data analysis. Only a tiny fraction are involved. Second, with $140-$150 million in cash, Missling can well afford to hire however many consultants he needs to get things done in a timely manner, especially when it comes to Anavex’s most advanced program. There is overwhelming evidence that he does things on the cheap while hoarding cash for no apparent reason. You get what you pay for.
The funny thing is that the WGTers never learn. They are either old and sick and therefore desperate for an effective new treatment or they simply cannot admit to the possibility of being wrong.
The same thing has been said every year for a decade. It never happens. Missling can’t get anything done in the time frames he himself puts out there publicly. Shorts have made fortunes because of it while longs have bled. There’s no evidence anything has changed or will change.
Keep trying. Maybe you’ll find a few new suckers.
Lack of resources vs. Sanofi... I'll add this excuse to my long list of excuses to let Missling off the hook.
Anavex has around $140-$150 million in cash. They can well afford to spend more money on external resources on their most important programs in order to get the job done in a timely manner.
Lack of resources is nothing more than another lame excuse.
Missling is cheap. He does everything on the cheap while hoarding cash for no good reason.
Wow. Three exclamation points is significant!!!
He did. Same as every week.
AD is largely a lifestyle disease. While a healthy lifestyle is important, it’s not a 100% guarantee. But the bottom line is don’t smoke and don’t drink (or at least limit alcohol consumption), eat a healthy diet (including lots of fruit and vegetables), get enough sleep, get hearing aids if you have hearing loss, exercise regularly, treat high blood pressure and high cholesterol, and maintain a good social life. If you do all of those things, your risk of developing AD is significantly reduced. More info here: https://www.nih.gov/news-events/news-releases/combination-healthy-lifestyle-traits-may-substantially-reduce-alzheimers
In my opinion, vitamins and other supplements should be regulated. The claims made for many of the products that are advertised and sold (like Prevagen and Balance of Nature) are dubious at best, and they are very expensive. Just because vitamins and supplements are unregulated doesn’t mean they are necessarily safe or effective. Nobody should be taking vitamins or supplements without first consulting their primary care doc.
Enough already! There are very good reasons for the high bar drugs must clear in order to be sold to patients. The number one reason is that drugs must be proven safe and effective to the satisfaction of drug regulators (not to message board posters with an equity position). Absence that, we as consumers have no way to know whether the drugs we’re taking are helpful or harmful. Blarcamesine has not yet been proven worthy of regulatory approval. More to the point, Missling has not even filed for regulatory approval.
If you want Blarcamesine, tell Missling to seek regulatory approval.
Missling must be raising cash through the ATM.
Yes, and yet there are those who will fall for it hook, line and sinker.
Another useless publication with sponsored news articles. Here’s more from mediabiasfactcheck. https://mediabiasfactcheck.com/rocketnews/
Nice try at pumping.
Huh? Georgejjl said to expect GREAT NEWS this week. I'm simply asking him to define GREAT NEWS. As most of us know by now, Georgejjl’s bar for GREAT NEWS is extremely low, which all but guarantees that he can declare that he was right.
Please define GREAT NEWS so that we will have a benchmark to judge whether your prediction comes true.
We are waiting…
Anavex is not an Alzheimer’s company. It’s a CNS company. Alzheimer’s is just one indication among many.
It seems to me Biogen has been pretty successful in the space, as have Acadia/Neuren, among others.
Again, just one more excuse to let Missling off the hook.
FYI, smart money biotech investors don’t know which technologies will be successful, though they obviously do a lot of in-depth research. More than anything, they’re betting on the CEO’s ability to execute a solid strategy and business plan.
For many reasons, Missling clearly does not have the confidence of smart money biotech investors.
“Maybe Missling can grow into that person.”
Lovely thought but nothing’s changed since the beginning and there’s nothing to suggest anything will change in the future. People are who they are. You can make changes at the margins if you put in the effort but that’s about it.
Clearly you are divorced from the reality of Missling AND you have no idea how institutional investors think.
“What's the use in spending time on an Internet message board where the vast majority of postings are merely personal whinings and gripes?”
Some are already convinced beyond any doubt. Others are trying to sort fact from fiction. That’s the use. Plus it’s great free entertainment.
If, if, if… There’s a long history on this message board of letting Missling off the hook despite abundant evidence of his incompetence as a CEO and his failure to enhance shareholder value.
If someday Anavex under Missling’s leadership is successful, I’ll admit to being wrong about him. In the meantime, I see little reason to think this leopard will change his spots.
Missling is sloppy. His speech is sloppy, his conference calls are sloppy, he’s sloppy in interviews, his website is sloppy, he’s sloppy looking, he presents data in a sloppy way, and he runs the company in a sloppy way. Is it any wonder he’s not taken seriously by smart money biotech investors?
More than anything else, biotech investors are investing based on their confidence in the ability of the management team to execute a smart business plan, and enhance shareholder value in the process. Great science doesn’t matter if investors lack confidence in management.
It’s clear the smart money biotech investors don’t have the necessary confidence in our CEO.
Anavex needs a CEO who has a track record of success and is respected by the smart money biotech investors. Otherwise, they will continue to sit on the sidelines and we will wallow in retail land.
So basically the stock could higher, lower, or be flat. Very helpful.
I don’t give a rat’s ass about what Missling looks like. I was only responding to a ridiculous post from ihidfromtheX. What I do care about is that Missling is an incompetent CEO who has made himself wealthy while doing nothing for shareholders.
By the way, Branson is much better looking than Missling.
Missling’s hair is ridiculous. I don’t even think it’s real. He’s age 50+ with the hair of a high school kid. Nobody his age, let alone the CEO of a public company, has hair like that. And his attire is terrible. Cheap suits that don’t fit. No wonder serious investors don’t take him seriously. He’s got a fashion model on staff getting paid a lot of money for doing nothing except attending conferences with him but apparently she can’t or won’t take him shopping for decent suits.
There. Happy?
Apparently nothing to discuss today other than A, Alpha, and Omega. Oh, and also Georgejjl’s most recent prediction of GREAT news within two weeks didn’t come true (as usual).
Here’s a prediction: Sometime today Georgejjl will tell us to expect GREAT news within 2 weeks and also that the stock will close today at or near the high of the day.
“…are migraines considered to be under the category of “rare diseases”?”
Look it up on the Google machine and you’ll find the answer. Sheesh.
Baloney. It doesn’t take TA to know where this stock is going.
I don’t understand why you’re celebrating. The stock closed today at $5.13 a share, $7.75 on September 11, 2023, $10.30 on September 9, 2022 and $18.91 on September 9, 2021.
You’re not fooling anybody (at least I hope not).
So basically you’re saying toward the end of the month the stock could go up, it could go down, or it could be flat. Have I got that right?
Oh My God, you got it right! Woo hoo! Brilliant!
And the news was so big the stock is now under $5.00!
You may have to find a new career. Pumper doesn’t suit you.